> top > docs > PMC:7534795 > spans > 36918-37889 > annotations

PMC:7534795 / 36918-37889 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T288 31-43 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T289 188-194 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T290 541-544 Disease denotes ARB http://purl.obolibrary.org/obo/MONDO_0012733
T291 684-690 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T253 364-365 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T282 207-213 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T283 236-242 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T284 257-263 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T285 270-282 Chemical denotes Atorvastatin http://purl.obolibrary.org/obo/CHEBI_39548
T286 338-345 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631
T287 391-403 Chemical denotes atorvastatin http://purl.obolibrary.org/obo/CHEBI_39548
T288 469-475 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T289 568-574 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T290 620-626 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T291 719-721 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T293 738-744 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T294 851-857 Chemical denotes statin http://purl.obolibrary.org/obo/CHEBI_87631
T295 930-937 Chemical denotes statins http://purl.obolibrary.org/obo/CHEBI_87631

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T91 31-43 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T256 0-94 Sentence denotes • Statin therapy and impact on inflammation and patient prognosis • Retrospective cohort study
T257 95-143 Sentence denotes • Primary endpoint of 28-day all-cause mortality
T258 144-194 Sentence denotes • Secondary endpoint included acute cardiac injury
T259 195-217 Sentence denotes • N = 1219 statin use
T260 218-267 Sentence denotes • N = 12, 762 no statin • In-hospital statin use
T261 268-289 Sentence denotes • Atorvastatin 83.2%,
T262 290-310 Sentence denotes • Rosuvastatin 15.6%
T263 311-521 Sentence denotes • Dose differences between statins were converted to a daily equivalent dose of atorvastatin ranging from 18.9–20.0 mg/day • Reduced all-cause mortality with statin use hazard ratio (HR) 0.63 (95% CI 0.48–0.84)
T264 522-632 Sentence denotes • Patients on ACEi/ARB therapy in addition to statin did not have increased mortality compared to statin alone
T265 633-690 Sentence denotes • Statin therapy not associated with acute cardiac injury
T266 691-971 Sentence denotes • Inflammatory markers CRP, IL-6 were lower in statin treated patients while in hospital • Reduced mortality and improved prognosis associated with in-hospital statin use may be due to the anti-inflammatory and immunomodulatory effects of statins (Zhang, Qin, Cheng, et al., 2020)

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1183 714-717 Gene denotes CRP Gene:1401
1184 719-723 Gene denotes IL-6 Gene:3569
1186 48-55 Species denotes patient Tax:9606
1187 524-532 Species denotes Patients Tax:9606
1188 753-761 Species denotes patients Tax:9606
1202 31-43 Disease denotes inflammation MESH:D007249
1203 180-199 Disease denotes cardiac injury • N MESH:D006331
1204 454-463 Disease denotes mortality MESH:D003643
1205 598-607 Disease denotes mortality MESH:D003643
1206 676-705 Disease denotes cardiac injury • Inflammatory MESH:D006331
1207 790-799 Disease denotes mortality MESH:D003643